Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 1,695 shares at $6.00 ($10K) on 2017-08-11, disclosed to the SEC on 2017-08-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | SELL | 2024-06-18 | $5.9M | — | Filing → |